Copyright © DrugPatentWatch. Initially revealed at New patent expiration for Pf Prism drug CHANTIX
Annual Drug Patent Expirations for CHANTIX
Chantix is a drug marketed by Pf Prism Cv and is included in a single NDA. It’s accessible from 4 suppliers. There are two patents defending this drug and one Paragraph IV problem.
CHANTIX drug worth tendencies.
Drug patent litigation for CHANTIX.
The generic ingredient in CHANTIX is varenicline tartrate. 4 suppliers are listed for this compound. Extra particulars can be found on the varenicline tartrate profile web page.
For extra data on how DrugPatentWatch can assist together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially revealed at New patent expiration for Pf Prism drug CHANTIX
